Neurotez, Inc.

Bridgewater, NJ 08807

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $3.47MM
First Award Date 05/15/07
Most Recent Award Date 08/01/11

Key Personnel

Last Name Name Awards Contact
Tezapsidis Nikolaos Tezapsidis 5
Ashford John Wesson Ashford 3

5 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 08/01/11 - 07/31/13

Leptin has been considered as a novel treatment for Alzheimer?s disease (AD), but we lack adequate evidence of a biological signal indicative of a therapeutic effect in patients with AD. Some concerns are related to side effects, along with uncertainty about dosing. We will therefore perform a pilot study in patients with AD that is sufficient i...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 08/01/10 - 07/31/11

Leptin has been considered as a novel treatment for Alzheimer?s disease (AD), but we lack adequate evidence of a biological signal indicative of a therapeutic effect in patients with AD. Some concerns are related to side effects, along with uncertainty about dosing. We will therefore perform a pilot study in patients with AD that is sufficient i...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 08/01/09 - 07/31/10

Leptin has been considered as a novel treatment for Alzheimer?s disease (AD), but we lack adequate evidence of a biological signal indicative of a therapeutic effect in patients with AD. Some concerns are related to side effects, along with uncertainty about dosing. We will therefore perform a pilot study in patients with AD that is sufficient i...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-27
Budget: 04/01/08 - 07/31/09

DESCRIPTION (provided by applicant): Inflammation and lipid metabolism are both involved in the pathobiology of neurodegeneration in Alzheimer's disease (AD). A protein known to be a prominent regulator of both pathways is leptin. Leptin shares structural and functional characteristics with cytokines and additionally, controls energy metabolism....

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-27
Budget: 05/15/07 - 03/31/08

DESCRIPTION (provided by applicant): Inflammation and lipid metabolism are both involved in the pathobiology of neurodegeneration in Alzheimer's disease (AD). A protein known to be a prominent regulator of both pathways is leptin. Leptin shares structural and functional characteristics with cytokines and additionally, controls energy metabolism....